Details for New Drug Application (NDA): 211911

✉ Email this page to a colleague

NDA 211911 describes DURYSTA, which is a drug marketed by Abbvie and is included in one NDA. It is available from one supplier. There are nine patents protecting this drug. Additional details are available on the DURYSTA profile page.

The generic ingredient in DURYSTA is bimatoprost. There are twelve drug master file entries for this compound. Eleven suppliers are listed for this compound. Additional details are available on the bimatoprost profile page.

Summary for 211911

Tradename:	DURYSTA
Applicant:	Abbvie
Ingredient:	bimatoprost
Patents:	9

Pharmacology for NDA: 211911

Medical Subject Heading (MeSH) Categories for 211911

Antihypertensive Agents

Suppliers and Packaging for NDA: 211911

Tradename	Generic Name	Dosage	NDA	Application Type	Supplier	National Drug Code	Package Code	Package
DURYSTA	bimatoprost	IMPLANT;OPHTHALMIC	211911	NDA	Allergan, Inc.	0023-9652	0023-9652-01	1 IMPLANT in 1 POUCH (0023-9652-01)
DURYSTA	bimatoprost	IMPLANT;OPHTHALMIC	211911	NDA	Allergan, Inc.	0023-9652	0023-9652-03	1 IMPLANT in 1 POUCH (0023-9652-03)

Profile for product number 001

Active Rx/OTC/Discontinued:	RX	Dosage:	IMPLANT;OPHTHALMIC			Strength	10MCG
Approval Date:	Mar 4, 2020	TE:		RLD:	Yes
Patent:	⤷ Sign Up	Patent Expiration:	Apr 30, 2024	Product Flag?		Substance Flag?		Delist Request?
Patented Use:	REDUCTION OF INTRAOCULAR PRESSURE (IOP) IN PATIENTS WITH OPEN ANGLE GLAUCOMA(OAG) OR OCULAR HYPERTENSION (OHT) WITH A BIODEGRADABLE BIMATOPROST IMPLANT
Patent:	⤷ Sign Up	Patent Expiration:	Dec 19, 2026	Product Flag?	Y	Substance Flag?		Delist Request?
Patent:	⤷ Sign Up	Patent Expiration:	Apr 24, 2029	Product Flag?	Y	Substance Flag?		Delist Request?

Expired US Patents for NDA 211911

Subscribe to access the full database, or Sign Up
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	Patent No.	Patent Expiration
Abbvie	DURYSTA	bimatoprost	IMPLANT;OPHTHALMIC	211911-001	Mar 4, 2020	⤷ Sign Up	⤷ Sign Up
Abbvie	DURYSTA	bimatoprost	IMPLANT;OPHTHALMIC	211911-001	Mar 4, 2020	⤷ Sign Up	⤷ Sign Up
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>Patent No.	>Patent Expiration

Complete Access Available with Subscription

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.